Skip to main content
Top

Drugs

Issue 18/2018

Content (12 Articles)

Acknowledgement to Referees

  • ACKNOWLEDGEMENT TO REFEREES

Daunorubicin/Cytarabine Liposome: A Review in Acute Myeloid Leukaemia

  • Open Access
  • Adis Drug Evaluation

Hannah A. Blair

Omadacycline: First Global Approval

  • AdisInsight Report

Anthony Markham, Susan J. Keam

Talazoparib: First Global Approval

  • AdisInsight Report

Sheridan M. Hoy

Dacomitinib: First Global Approval

  • AdisInsight Report

Matt Shirley

Correction to: Caplacizumab: First Global Approval

  • Open Access
  • Correction

Sean Duggan

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images